EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY-NC 4.0

Intracardiac Thrombi in Behçet’s Disease: Systematic Review of 218 Patients’ Clinical Characteristics and Treatments

Anas M Barabrah iD, Anas R Tuqan, Sara M Darawish iD, Ameer Awashra iD, Mohammad H Shehadeh, Basel A Zaben iD, Mohammed Ayyad

European Cardiology Review · 18.06.2026

DOI: 10.15420/ecr.2025.63 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Cardiology Review, online erschienen am 18.06.2026. Verfasst von Anas M Barabrah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Al-Quds University Jerusalem, Palestine. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Behçet’s disease (BD) is a rare autoimmune disorder with significant cardiovascular complications, including intracardiac thrombosis (ICT), which can lead to high morbidity and mortality.

Methods

We conducted a comprehensive literature search across multiple databases up to December 2024, identifying articles related to BD and ICT. Data were extracted from case reports and cohort studies, focusing on demographics, clinical presentations and treatment outcomes.

Results

A total of 218 cases of ICT in BD were analysed, predominantly affecting young males from regions along the historical Silk Road. ICT often presented as the initial manifestation of BD (53.21% of cases), with fever, dyspnoea and haemoptysis as common symptoms. The right heart chambers were most frequently involved. Treatment primarily involved corticosteroids, immunosuppressants and anticoagulants, with a complete resolution rate of 67.22% (n=160). Surgical interventions were associated with high recurrence and mortality rates of 60% and 34.78%, respectively.

Conclusion

ICT in BD is a serious complication that requires prompt recognition and management. A multimodal treatment approach combining corticosteroids, immunosuppressants and anticoagulants is recommended to improve outcomes. Surgical intervention carries a higher risk of mortality and morbidity, making it a less preferred treatment option. Clinicians should maintain a high index of suspicion for ICT in BD patients and initiate timely medical therapy to mitigate complications. Further studies are needed to optimise treatment strategies and explore long-term outcomes.

Schlagwörter

Stichwörter der Autor:innen

Behçet’s diseaseIntracardiac thrombosisautoimmune thrombosiscardiac involvementvascular complications

Autor:innen und Institutionen

  • Department of Medicine, Al-Quds University Jerusalem, Palestine.
  • Department of Medicine, An Najah National University Nablus, Palestine.
  • Department of Internal Medicine, Rutgers New Jersey Medical School Newark, NJ, US.

ORCID-Profile: Anas M Barabrah, Sara M Darawish, Ameer Awashra, Basel A Zaben

Zitieren

APA

Barabrah, A. M., Tuqan, A. R., Darawish, S. M., Awashra, A., Shehadeh, M. H., Zaben, B. A., & Ayyad, M. (2026). Intracardiac Thrombi in Behçet’s Disease: Systematic Review of 218 Patients’ Clinical Characteristics and Treatments. European Cardiology Review. https://doi.org/10.15420/ecr.2025.63

Vancouver

Barabrah AM, Tuqan AR, Darawish SM, Awashra A, Shehadeh MH, Zaben BA, et al. Intracardiac Thrombi in Behçet’s Disease: Systematic Review of 218 Patients’ Clinical Characteristics and Treatments. European Cardiology Review. 2026. doi:10.15420/ecr.2025.63

BibTeX
@article{Barabrah2026,
  author = {Barabrah, Anas M and Tuqan, Anas R and Darawish, Sara M and Awashra, Ameer and Shehadeh, Mohammad H and Zaben, Basel A and Ayyad, Mohammed},
  title = {Intracardiac Thrombi in Behçet’s Disease: Systematic Review of 218 Patients’ Clinical Characteristics and Treatments},
  journal = {European Cardiology Review},
  year = {2026},
  doi = {10.15420/ecr.2025.63}
}
Kostenlos starten →